Frederic Chibon

Summary

Affiliation: Institut Bergoni
Country: France

Publications

  1. ncbi Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
    Frederic Chibon
    Department of Pathology, Institut Bergonie, Bordeaux, France
    Mod Pathol 22:403-9. 2009
  2. ncbi Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
    Frederic Chibon
    Departement de Pathologie, Institut Bergonie, Bordeaux, France
    Nat Med 16:781-7. 2010
  3. ncbi MED12 alterations in both human benign and malignant uterine soft tissue tumors
    Gaëlle Pérot
    INSERM U916, Institut Bergonié Cancer Institute, Bordeaux, France
    PLoS ONE 7:e40015. 2012
  4. ncbi Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics
    Antoine Italiano
    Department of Medical Oncology, INSERM U916, Institut Bergonie, Bordeaux, France
    Clin Cancer Res 19:1190-6. 2013
  5. ncbi Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis
    Nathalie Stock
    Bergonié Institute and INSERM U 916, Bordeaux, France
    Am J Surg Pathol 33:1850-9. 2009
  6. ncbi Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
    Pauline Lagarde
    Tumor Genetics Department of Pathology, Institut Bergonie, 229 Cours de l Argonne, Bordeaux, France 33076
    J Clin Oncol 31:608-15. 2013
  7. ncbi Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases
    Nadège Dreux
    Department of Pathology, Institut Bergonie, 229 Cours de l Argonne, Bordeaux Cedex, France
    Mod Pathol 23:1657-66. 2010
  8. ncbi Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors
    Sébastien Salas
    Department of Pathology, INSERM U916, Bergonie Institute, 229 Cours de l Argonne, Bordeaux Cedex, France
    Genes Chromosomes Cancer 49:560-8. 2010

Collaborators

Detail Information

Publications8

  1. ncbi Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
    Frederic Chibon
    Department of Pathology, Institut Bergonie, Bordeaux, France
    Mod Pathol 22:403-9. 2009
    ..Pathological factors, in particular SBR grade 3 and more than 60% Her2+ cells, were significantly correlated with HER2 amplification...
  2. ncbi Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
    Frederic Chibon
    Departement de Pathologie, Institut Bergonie, Bordeaux, France
    Nat Med 16:781-7. 2010
    ..Application of the signature will permit more selective use of adjuvant therapies for people with sarcomas, leading to decreased iatrogenic morbidity and improved outcomes for such individuals...
  3. ncbi MED12 alterations in both human benign and malignant uterine soft tissue tumors
    Gaëlle Pérot
    INSERM U916, Institut Bergonié Cancer Institute, Bordeaux, France
    PLoS ONE 7:e40015. 2012
    ..We propose here that MED12 alterations could be implicated in the development of smooth muscle tumor and that its expression could be inhibited in malignant tumors...
  4. ncbi Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics
    Antoine Italiano
    Department of Medical Oncology, INSERM U916, Institut Bergonie, Bordeaux, France
    Clin Cancer Res 19:1190-6. 2013
    ..Data about the prognostic factors of soft-tissue leiomyosarcomas and their correlation with molecular profile are limited...
  5. ncbi Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis
    Nathalie Stock
    Bergonié Institute and INSERM U 916, Bordeaux, France
    Am J Surg Pathol 33:1850-9. 2009
    ..In conclusion, adult-type RMS is a rare sarcoma occurring mainly in the extremities and trunk wall with 2 main histologic patterns, spindle cell, and pleomorphic patterns, which represent the end of the spectrum of a single entity...
  6. ncbi Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
    Pauline Lagarde
    Tumor Genetics Department of Pathology, Institut Bergonie, 229 Cours de l Argonne, Bordeaux, France 33076
    J Clin Oncol 31:608-15. 2013
    ..Genomic Index is potentially the best overall biomarker and clearly the most clinically relevant, considering that genome profiling from formalin-fixed samples is already used in pathology...
  7. ncbi Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases
    Nadège Dreux
    Department of Pathology, Institut Bergonie, 229 Cours de l Argonne, Bordeaux Cedex, France
    Mod Pathol 23:1657-66. 2010
    ..Finally, and may be more importantly, HMGA2 is useful for the diagnosis of benign fibrous histiocytoma, nodular fasciitis and vulvovaginal benign mesenchymal tumors...
  8. ncbi Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors
    Sébastien Salas
    Department of Pathology, INSERM U916, Bergonie Institute, 229 Cours de l Argonne, Bordeaux Cedex, France
    Genes Chromosomes Cancer 49:560-8. 2010
    ..A better understanding of the pathogenetic pathways in the initiation and progression of desmoid tumors requires studies of 8q and 20q gains, as well as of 6q and 5q losses, and study of the Wnt/beta-catenin pathway...